Accueil
Détail de l'auteur
Auteur K. SKARUPOVA |
Documents disponibles écrits par cet auteur (10)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
OEDT = EMCDDA ; C. CARPENTIER ; K. MULLIGAN ; L. LANIEL ; D. J. POTTER ; B. HUGHES ; L. VANDAM ; D. OLSZEWSKI ; K. SKARUPOVA | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2012FRANÇAIS : « La part de marché de l'herbe de cannabis augmente en Europe, aux dépens de celle de la résine de cannabis ». Telle est l'information qui ressort de la première analyse détaillée de la Production et des marchés du cannabis en Europe[...]Rapport
The aim of the present report is to collect information from a literature review on computer-assisted interviewing and online data collection in general population surveys. It evaluates the pros and cons of both approaches in terms of research p[...]Rapport
This report is based on work commissioned by the EMCDDA in 2009. It examines differences in methods and results between general population surveys conducted in a single context (focusing exclusively on substance use) and a multi context (focusin[...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA ; T. NÉFAU ; E. LEFRANÇOIS ; T. SEYLER | Lisbon : OEDT / EMCDDA | Rapid communication | 2019This report presents the results of an innovative method for gathering information on the substances used by people who inject drugs. In this pilot study, chemical analysis of the contents of used syringes collected from exchange sites reveals t[...]Rapport
This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EWSD). Data quality has various dimensions, such as accuracy, consistency, validity and completeness, but can be defined as fitness of the data for the[...]Article : Périodique
K. SKARUPOVA ; N. SINGLETON ; J. MATIAS ; V. MRAVCIK |Background: The European Web Survey on Drugs aimed to obtain in-depth data on consumption of cannabis, ecstasy/MDMA, cocaine, and amphetamines in different populations of drug users in 16 European countries. This paper examines test-retest relia[...]Article : Périodique
L. MONTANARI ; R. TELTZROW ; S. VANMALDEREN ; R. RANIERI ; J. A. MARTIN PELAEZ ; L. VANDAM ; J. MOUNTENEY ; A. PIRONA ; F. MEROUEH ; I. GIRAUDON ; J. MATIAS ; K. SKARUPOVA ; L. ROYUELA ; J. MOREL D'ARLEUX |Purpose: This paper aims to describe the impact of the COVID-19 containment measures on the provision of drug treatment and harm reduction services in European prisons in15 countries during the early phase of the pandemic (March-June 2020). Des[...]Rapport
OEDT = EMCDDA ; K. SKARUPOVA | Lisbon : OEDT / EMCDDA | EMCDDA Literature reviews, ISSN 1725-0579 | 2014This report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/amphetamine. The behavioural factors that were [...]Article : Périodique
J. MATIAS ; E. KALAMARA ; F. MATHIS ; K. SKARUPOVA ; A. NOOR ; N. SINGLETON |Background: Most comparative drug policy analyses utilise measures of drug use, often from general population surveys (GPS). However, the limitations of GPS are well-recognised, including the small numbers of people who use illicit drugs sampled[...]Article : Périodique
BACKGROUND In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report revie[...]